ADCC directs immune cells to kill targets. Biointron explains how this mechanism underpins therapeutic antibody efficacy in oncology and virology.
Effector functions drive antibody impact. Biointron reviews ADCC, CDC, and other mechanisms that enable antibodies to protect health and guide new therapies.
Afucosylated antibodies enhance ADCC for stronger therapies. Biointron highlights their mechanism and clinical applications improving efficacy across treatments.
Antibodies defend health by neutralizing pathogens, aiding phagocytosis, and activating complement. Biointron explains these vital functions in immunity and therapy.
Antibodies neutralize pathogens, opsonize invaders, and activate complement. Biointron highlights these essential functions as the foundation for antibody drug development.
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.




